Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

Vedanta Biosciences Key Microbiome Patent Upheld in European Opposition Proceedings

Source: 
CP Wire
snippet: 

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, announced on 5/7/19 that the Opposition Division of the European Patent Office has upheld Vedanta’s foundational patent EP2575835 (the “Honda patent”), strengthening Vedanta’s intellectual property position in a key area of microbiome therapeutics.